Short interest screen · refreshed after the Nov 9, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 151 | SLDBSolid BiosciencesHealthcare | $7.05 | +6.98% | 8.5 | 17.8% | −3% | $786.9M |
| 152 | VCYTVeracyteHealthcare | $25.41 | +5.17% | 8.5 | 12.3% | −4% | $2.05B |
| 153 | EWTXEdgewise TherapeuticsHealthcare | $46.30 | +2.80% | 8.5 | 16.7% | +5% | $5.07B |
| 154 | SHCSotera HealthHealthcare | $16.46 | +2.81% | 8.4 | 6.2% | +9% | $4.70B |
| 155 | QTRXQuanterixHealthcare | $3.06 | +5.53% | 8.4 | 10.8% | −7% | $144.5M |
| 156 | ARCTArcturus Therapeutics HoldingsHealthcare | $10.29 | −0.58% | 8.4 | 24.0% | +2% | $292.9M |
| 157 | TMCITreace Medical ConceptsHealthcare | $4.91 | +21.84% | 8.3 | 4.0% | −3% | $319.3M |
| 158 | MPLTMapLight TherapeuticsHealthcare | $7.42 | +7.00% | 8.3 | 24.6% | +6% | $412.1M |
| 159 | VNDAVanda PharmaceuticalsHealthcare | $4.01 | +4.97% | 8.3 | 15.4% | +6% | $242.5M |
| 160 | NPCENeuropaceHealthcare | $13.22 | +5.72% | 8.3 | 3.7% | −2% | $453.6M |
| 161 | SGMTSagimet Biosciences Inc. Series AHealthcare | $10.65 | +8.07% | 8.2 | 18.7% | +3% | $754.8M |
| 162 | NATRNature's Sunshine ProductsHealthcare | $10.94 | +0.60% | 8.2 | 6.4% | +7% | $189.5M |
| 163 | TDOCTeladoc HealthHealthcare | $9.09 | +3.59% | 8.2 | 17.8% | +7% | $1.66B |
| 164 | CGEMCullinan TherapeuticsHealthcare | $12.20 | +7.87% | 8.2 | 14.3% | 0% | $785.1M |
| 165 | MGNXMacroGenicsHealthcare | $2.42 | +3.86% | 8.2 | 8.2% | −28% | $154.2M |
| 166 | ARVNArvinasHealthcare | $6.64 | +3.51% | 8.2 | 10.2% | +4% | $434.5M |
| 167 | OCULOcular TherapeutixHealthcare | $6.66 | +0.99% | 8.1 | 15.1% | −2% | $1.46B |
| 168 | DNLIDenali TherapeuticsHealthcare | $20.30 | +1.15% | 8.1 | 11.6% | 0% | $3.25B |
| 169 | VRDNViridian TherapeuticsHealthcare | $30.23 | +6.11% | 8.0 | 18.5% | 0% | $3.43B |
| 170 | GRALGRAILHealthcare | $127.55 | +5.03% | 8.0 | 19.3% | +2% | $5.73B |
| 171 | GENBGenerate BiomedicinesHealthcare | $14.13 | +8.19% | 8.0 | 15.4% | +20% | $1.81B |
| 172 | IRWDIronwood Pharmaceuticals, Inc. -Healthcare | $4.74 | +7.86% | 8.0 | 10.6% | +2% | $783.9M |
| 173 | ROIVRoivant SciencesHealthcare | $40.71 | +4.69% | 7.9 | 8.0% | +3% | $29.40B |
| 174 | KODKEASTMAN KODAKHealthcare | $8.28 | +3.37% | 7.9 | 11.8% | +8% | $812.3M |
| 175 | LYELLyell ImmunopharmaHealthcare | $16.80 | +13.06% | 7.9 | 15.8% | +11% | $413.0M |
| 176 | ICUIICU MedicalHealthcare | $179.82 | +4.48% | 7.8 | 7.0% | +12% | $4.50B |
| 177 | COAGHemab Therapeutics HoldingsHealthcare | $44.84 | −8.54% | 7.8 | 13.7% | −7% | $2.09B |
| 178 | FTHFaeth TherapeuticsHealthcare | $12.25 | −44.44% | 7.8 | 20.5% | +12% | $316.6M |
| 179 | NVCRNovoCure LimitedHealthcare | $12.74 | −4.07% | 7.7 | 12.2% | +15% | $1.49B |
| 180 | BBIOBridgeBio PharmaHealthcare | $77.35 | +4.12% | 7.7 | 12.5% | +2% | $15.07B |
| 181 | IONSIonis PharmaceuticalsHealthcare | $29.82 | −24.37% | 7.7 | 12.6% | −8% | $4.95B |
| 182 | SNDXSyndax PharmaceuticalsHealthcare | $9.58 | +0.37% | 7.6 | 21.4% | −1% | $862.0M |
| 183 | SEPNSepternaHealthcare | $49.20 | +0.72% | 7.6 | 12.0% | +14% | $2.30B |
| 184 | RCELAvita MedicalHealthcare | $17.34 | +4.49% | 7.6 | 9.4% | −2% | $544.7M |
| 185 | INFUInfuSystem HoldingsHealthcare | $14.71 | +7.45% | 7.6 | 4.9% | −6% | $294.6M |
| 186 | KARDKardiganHealthcare | $15.86 | +2.19% | 7.6 | 13.8% | +19% | $1.48B |
| 187 | SNDASonida Senior LivingHealthcare | $33.51 | +2.23% | 7.6 | 12.9% | +8% | $1.65B |
| 188 | PTCTPTC TherapeuticsHealthcare | $64.80 | −0.99% | 7.6 | 10.5% | −9% | $5.41B |
| 189 | IMMXImmix BiopharmaHealthcare | $8.74 | +8.44% | 7.5 | 22.5% | +3% | $724.6M |
| 190 | ANROAlto NeuroscienceHealthcare | $27.83 | +10.61% | 7.5 | 20.0% | +12% | $1.09B |
| 191 | MBXMBX BiosciencesHealthcare | $53.94 | +5.03% | 7.5 | 15.0% | −1% | $2.60B |
| 192 | SRPTSarepta Therapeutics,Healthcare | $17.61 | −1.18% | 7.5 | 22.7% | −2% | $1.89B |
| 193 | ELVNEnliven TherapeuticsHealthcare | $51.25 | +3.67% | 7.5 | 16.4% | −10% | $3.77B |
| 194 | PRAXPraxis Precision MedicinesHealthcare | $311.00 | +12.02% | 7.4 | 14.1% | −6% | $8.68B |
| 195 | IRDOpus GeneticsHealthcare | $4.31 | +3.11% | 7.4 | 21.4% | +2% | $358.6M |
| 196 | FLGTFulgent GeneticsHealthcare | $24.70 | +4.02% | 7.4 | 12.0% | −5% | $690.0M |
| 197 | WHWKWhitehawk TherapeuticsHealthcare | $3.24 | +3.51% | 7.4 | 8.7% | −3% | $184.7M |
| 198 | ANTXAN2 TherapeuticsHealthcare | $4.00 | 0.00% | 7.4 | 10.0% | +16% | $150.9M |
| 199 | DYNDyne TherapeuticsHealthcare | $18.75 | +3.76% | 7.4 | 14.6% | −2% | $3.51B |
| 200 | BBNXBeta BionicsHealthcare | $16.72 | +6.50% | 7.4 | 24.4% | +14% | $909.0M |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.